Business Description
Talphera Inc
NAICS : 325411
SIC : 2833
ISIN : US00444T1007
Description
Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.46 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | -31.62 | |||||
| Beneish M-Score | -3.23 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -66.9 | |||||
| 3-Year EBITDA Growth Rate | 56.3 | |||||
| 3-Year EPS without NRI Growth Rate | 57.5 | |||||
| 3-Year FCF Growth Rate | 49.3 |
Momentum Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 42.95 | |||||
| 9-Day RSI | 40.53 | |||||
| 14-Day RSI | 40.69 | |||||
| 6-1 Month Momentum % | -19.43 | |||||
| 12-1 Month Momentum % | -6.2 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 4.42 | |||||
| Quick Ratio | 4.42 | |||||
| Cash Ratio | 4.02 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -50.8 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Operating Margin % | -5885.77 | |||||
| Net Margin % | -5569.75 | |||||
| FCF Margin % | -5116.67 | |||||
| ROE % | -110.04 | |||||
| ROA % | -66.15 | |||||
| ROIC % | -165.99 | |||||
| ROCE % | -75.62 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 41.22 | |||||
| PB Ratio | 1.09 | |||||
| Price-to-Tangible-Book | 11.64 | |||||
| EV-to-EBIT | -0.01 | |||||
| EV-to-Forward-EBIT | -0.34 | |||||
| EV-to-EBITDA | -0.01 | |||||
| EV-to-Revenue | 0.47 | |||||
| EV-to-Forward-Revenue | 10.54 | |||||
| EV-to-FCF | -0.01 | |||||
| Price-to-Net-Current-Asset-Value | 11.64 | |||||
| Earnings Yield (Greenblatt) % | -10000 | |||||
| FCF Yield % | -136.57 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Talphera Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 0.258 | ||
| EPS (TTM) (€) | -0.596 | ||
| Beta | -1.13 | ||
| Volatility % | 61.27 | ||
| 14-Day RSI | 40.69 | ||
| 14-Day ATR (€) | 0.022139 | ||
| 20-Day SMA (€) | 0.63835 | ||
| 12-1 Month Momentum % | -6.2 | ||
| 52-Week Range (€) | 0.572 - 1.328 | ||
| Shares Outstanding (Mil) | 17.03 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Talphera Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Talphera Inc Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Talphera Inc Frequently Asked Questions
What is Talphera Inc(FRA:R5XA)'s stock price today?
The current price of FRA:R5XA is €0.58. The 52 week high of FRA:R5XA is €1.33 and 52 week low is €0.57.
When is next earnings date of Talphera Inc(FRA:R5XA)?
The next earnings date of Talphera Inc(FRA:R5XA) is 2025-03-06 Est..
Does Talphera Inc(FRA:R5XA) pay dividends? If so, how much?
Talphera Inc(FRA:R5XA) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers